Key stats
About KODEX GLOBAL OBESITY TREATMENT TOP2 PLUS
Home page
Inception date
Feb 14, 2024
Replication method
Physical
Primary advisor
Samsung Asset Management Co., Ltd.
ISIN
KR7476070008
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Cash
Stocks49.54%
Health Technology49.54%
Bonds, Cash & Other50.46%
Cash50.46%
Stock breakdown by region
North America58.26%
Europe41.74%
Latin America0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Symbol
Assets
Symbol
Assets
K
Korean Won
50.46%
L
Eli Lilly and CompanyLLY
15.35%
N
Novo Nordisk A/S Sponsored ADR Class BNVO
10.52%
R
Roche Holding Ltd Dividend Right Cert.ROG
3.84%
A
Amgen Inc.AMGN
3.73%
A
AstraZeneca PLC Sponsored ADRAZN
3.71%
R
Rhythm Pharmaceuticals, Inc.RYTM
3.01%
R
Regeneron Pharmaceuticals, Inc.REGN
2.91%
Z
Zealand Pharma A/SZEAL
2.62%
G
Structure Therapeutics, Inc. Sponsored ADRGPCR
2.14%
Top 10 weight98.28%
11 total holdings
Dividends
Apr '24
Jul '24
Oct '24
Jan '25
0.00
15.00
30.00
45.00
60.00
Dividend amount
Dividend payout history
Ex-date
Record date
Pay date
Amount
Frequency
Jan 24, 2025
Jan 31, 2025
Feb 4, 2025
10.000
Interim
Oct 30, 2024
Oct 31, 2024
Nov 4, 2024
15.000
Final
Jul 30, 2024
Jul 31, 2024
Aug 2, 2024
18.000
Interim
Apr 29, 2024
Apr 30, 2024
May 3, 2024
56.000
Interim